Paller A, Cork M, Hong C- ho, Soong W, Schneider S, Lo H, Pedersen LRM, Vacko E, Wollenberg A. Laboratory Parameters in Adolescent Patients Aged 12–17 with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52: Results from the Phase 3 ECZTRA 6 Trial. J of Skin [Internet]. 2024 Jan. 16 [cited 2024 Jul. 3];8(1):s323. Available from: https://jofskin.org/33014/index.php/skin/article/view/2407